We have an exceptional group of directors and advisors who are making sure we fulfill our global mission.
Francesca Domenech Wuttke, Ph.D. is a Managing Director focused on identifying new investment opportunities in Europe for the Merck Global Health Innovation Fund, LLC. Dr. Wuttke brings with her broad drug development and healthcare expertise in both the US and Europe, with over 20 years of clinical, commercial, strategic and transactional experience. She has worked with diverse organizations including start-ups, consulting, large and specialty pharma as well as academia. Most recently Dr. Wuttke led Almirall´s Corporate Development Strategy team to transact on both med device and pharma M&A opportunities with a new and targeted focus for the company. Before that Dr. Wuttke worked at Novartis where she was responsible for two Cell and Gene therapy opportunities that were successfully brought into the organization as well as managing the strategy and commercialization for the existing portfolio of cell therapy assets. Dr. Wuttke holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences.
Aarti is a Senior Associate at Smedvig Capital, which she joined in 2013. Prior to Smedvig Capital, Aarti started her career in Investment Banking at Merrill Lynch and then moved to Bain & Company where she worked on strategic projects for FTSE 100 clients and leading private equity funds.
Aarti has an MA in Economics and Management from Oxford University as well as a Masters in Architecture & Design from the Inchbald School of Design.
Aarti spends most of her time focussing on Smedvig Capital’s portfolio, helping management teams to further grow their businesses and supporting them in driving and implementing strategic and operational initiatives. Aarti is currently an advisor to Kings Court Trust, The Smart Cube, Antidote and Quill, and has previously worked with Captify.